Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.


TSXV:COV - Post by User

Bullboard Posts
Comment by Joseph_Kon Jan 03, 2017 1:52pm
113 Views
Post# 25662528

RE:RE:High Gross Margin Generate strong profits

RE:RE:High Gross Margin Generate strong profitsWow, such a professional pump!

Personally I'd like to see the first quarter of profits before I start dreaming of 50x P/E multiples.   COV did lose money last year after all.

Remember how high the hype drove it in the summer, and then how far it fell after the August quarterly results were reported.  It was nearly cut in half a few months later.  Growing revenue is great, but when cost of sales and expenses are giving you losses, you have to start wondering if you are in too soon, or at least asking youself how long you will have to wait to see those theoretical future profits.

But by all means, lets hype it up again and hope they deliver some profits when the next quarter's numbers are released.   Lets hope for some Saudi re-orders when the contract is up as well.

zenvesting wrote: Your P/E expectation is low given the forecast for growth of more than 100% to get to $20M, but I also think your net earnings expectations are high given that we see the company is already investing in new senior regulatory and Q/A personnel. I might hope for the company to allow $3 million to fall to the bottom line, giving the 20 million shares a $0.15 EPS; but would expect the market to assign a P/E north of 50 for a company growing this fast (particularly if we get news of renewals in Saudi Arabia this year and other signs of continued growth), so as to achieve a stock price of $7.50 with a modest PEG of 0.5! Many think a PEG of 1 is fair value.....so if the growth appears to be conntinuing strong, I think we actually could see a share price around $15 on a modest 15 cents earnings from the 100%+ growth. Their company's earnings power is debateable until we see some results reflecting the new business, but the growth forecast is definitely exciting and we should expect it will definitely be an exciting 2017 here!!!!


Bullboard Posts